{"title":"Comparison of prestroke frailty and disability for outcome prediction in older stroke patients","authors":"Paola Forti , Marianna Ciani , Fabiola Maioli","doi":"10.1016/j.jns.2025.123606","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Prestroke disability, measured by the modified Rankin Scale (mRS), is routinely used in older (≥65 years) patients to predict stroke outcomes. Frailty, a common geriatric syndrome, is also associated with poor health outcomes but is rarely assessed in older stroke patients. The Clinical Frailty Scale (CFS) is a simple frailty assessment tool; however, its prognostic value in stroke clinical practice remains uncertain. This study compares the predictive value of prestroke mRS and CFS for stroke outcomes in older patients.</div></div><div><h3>Methods</h3><div>We included 4086 older patients with acute stroke (82.6 % ischemic), consecutively admitted to an Italian hospital. The median age was 81 years (25th–75th percentile: 75–87 years). Prestroke mRS was assessed at admission, while prestroke CFS was retrospectively evaluated from medical records. Multivariable-adjusted models tested the association of each scale with prolonged admission, unfavorable discharge setting, and mortality at 30 days and 1 year. For each outcome, the predictive value of the mRS and CFS scales was compared using the difference in Akaike's Information Criterion (AIC) between the respective models (AIC<sub>mRS-CFS</sub>).</div></div><div><h3>Results</h3><div>Both mRS and CFS were positively associated with unfavorable discharge and mortality and inversely associated with prolonged admission. However, based on AIC<sub>mRS-CFS,</sub> CFS was a stronger outcome predictor than mRS. In ischemic stroke patients receiving reperfusion therapies, CFS was also superior to mRS in predicting neurological improvement following treatment and the likelihood of discharge to long-term care.</div></div><div><h3>Conclusions</h3><div>Compared to prestroke mRS, prestroke CFS may offer additional prognostic information in older stroke patients.</div></div>","PeriodicalId":17417,"journal":{"name":"Journal of the Neurological Sciences","volume":"476 ","pages":"Article 123606"},"PeriodicalIF":3.2000,"publicationDate":"2025-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Neurological Sciences","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0022510X25002230","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Prestroke disability, measured by the modified Rankin Scale (mRS), is routinely used in older (≥65 years) patients to predict stroke outcomes. Frailty, a common geriatric syndrome, is also associated with poor health outcomes but is rarely assessed in older stroke patients. The Clinical Frailty Scale (CFS) is a simple frailty assessment tool; however, its prognostic value in stroke clinical practice remains uncertain. This study compares the predictive value of prestroke mRS and CFS for stroke outcomes in older patients.
Methods
We included 4086 older patients with acute stroke (82.6 % ischemic), consecutively admitted to an Italian hospital. The median age was 81 years (25th–75th percentile: 75–87 years). Prestroke mRS was assessed at admission, while prestroke CFS was retrospectively evaluated from medical records. Multivariable-adjusted models tested the association of each scale with prolonged admission, unfavorable discharge setting, and mortality at 30 days and 1 year. For each outcome, the predictive value of the mRS and CFS scales was compared using the difference in Akaike's Information Criterion (AIC) between the respective models (AICmRS-CFS).
Results
Both mRS and CFS were positively associated with unfavorable discharge and mortality and inversely associated with prolonged admission. However, based on AICmRS-CFS, CFS was a stronger outcome predictor than mRS. In ischemic stroke patients receiving reperfusion therapies, CFS was also superior to mRS in predicting neurological improvement following treatment and the likelihood of discharge to long-term care.
Conclusions
Compared to prestroke mRS, prestroke CFS may offer additional prognostic information in older stroke patients.
期刊介绍:
The Journal of the Neurological Sciences provides a medium for the prompt publication of original articles in neurology and neuroscience from around the world. JNS places special emphasis on articles that: 1) provide guidance to clinicians around the world (Best Practices, Global Neurology); 2) report cutting-edge science related to neurology (Basic and Translational Sciences); 3) educate readers about relevant and practical clinical outcomes in neurology (Outcomes Research); and 4) summarize or editorialize the current state of the literature (Reviews, Commentaries, and Editorials).
JNS accepts most types of manuscripts for consideration including original research papers, short communications, reviews, book reviews, letters to the Editor, opinions and editorials. Topics considered will be from neurology-related fields that are of interest to practicing physicians around the world. Examples include neuromuscular diseases, demyelination, atrophies, dementia, neoplasms, infections, epilepsies, disturbances of consciousness, stroke and cerebral circulation, growth and development, plasticity and intermediary metabolism.